当前位置: 首页 > 详情页

To Accelerate the Process of Brain Death Determination in China Through the Strategy and Practice of Establishing Demonstration Hospitals

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Xuanwu Hosp, Dept Neurol, Neurocrit Care Unit, Beijing 10053, Peoples R China [2]Brain Death Determinat Qual Control Demonstrat Hos, Beijing, Peoples R China [3]Inner Mongolia Peoples Hosp, Dept Neurol, Neurocrit Care Unit, Hohhot, Peoples R China [4]Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Neurol, Neurocrit Care Unit, Nanning, Peoples R China [5]Anhui Med Univ, Dept Neurol, Neurocrit Care Unit, Affiliated Hosp 1, Hefei, Peoples R China [6]Liangxiang Hosp Beijing Fangshan Dist, Dept Neurol, Beijing, Peoples R China
出处:
ISSN:

关键词: Brain death determination Standard Training Education Quality control

摘要:
BackgroundOur objective was to explore whether a brain death determination (BDD) strategy with demonstration hospitals can accelerate the process of BDD in China.MethodsWe proposed the construction standards for the BDD quality control demonstration hospitals (BDDHs). The quality and quantity of BDD cases were then analyzed.ResultsA total of 107 BDDHs were established from 2013 to 2022 covering 29 provinces, autonomous regions, and municipalities under jurisdiction of the central government of the Chinese mainland (except Qinghai and Tibet). A total of 1,948 professional and technical personnel from these 107 BDDHs received training in BDD, 107 quality control personnel were trained in the quality control management of BDD, and 1,293 instruments for electroencephalography, short-latency somatosensory evoked potential recordings, and transcranial Doppler imaging were provided for BDD. A total of 6,735 BDD cases were submitted to the quality control center. Among the nine quality control indicators for BDD in these cases, the implementation rate, completion rate, and coincidence rate of apnea testing increased the most, reaching 99%.ConclusionsThe strategy of constructing BDDHs to promote BDD is feasible and reliable. Ensuring quality and quantity is a fundamental element for the rapid and orderly popularization of BDD in China.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 危重病医学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 危重病医学
JCR分区:
出版当年[2022]版:
Q2 CLINICAL NEUROLOGY Q2 CRITICAL CARE MEDICINE
最新[2023]版:
Q2 CLINICAL NEUROLOGY Q2 CRITICAL CARE MEDICINE

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Capital Med Univ, Xuanwu Hosp, Dept Neurol, Neurocrit Care Unit, Beijing 10053, Peoples R China [2]Brain Death Determinat Qual Control Demonstrat Hos, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Xuanwu Hosp, Dept Neurol, Neurocrit Care Unit, Beijing 10053, Peoples R China [2]Brain Death Determinat Qual Control Demonstrat Hos, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院